Table of Content

1 Liposomes Drug Delivery Market Overview
1.1 Liposomes Drug Delivery Product Scope
1.2 Liposomes Drug Delivery Segment by Type
1.2.1 Global Liposomes Drug Delivery Sales by Type (2016 & 2021 & 2027)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposomes Drug Delivery Segment by Application
1.3.1 Global Liposomes Drug Delivery Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Liposomes Drug Delivery Market Estimates and Forecasts (2016-2027)
1.4.1 Global Liposomes Drug Delivery Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Liposomes Drug Delivery Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Liposomes Drug Delivery Price Trends (2016-2027)

2 Liposomes Drug Delivery Estimates and Forecasts by Region
2.1 Global Liposomes Drug Delivery Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Liposomes Drug Delivery Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Liposomes Drug Delivery Sales Market Share by Region (2016-2021)
2.2.2 Global Liposomes Drug Delivery Revenue Market Share by Region (2016-2021)
2.3 Global Liposomes Drug Delivery Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Liposomes Drug Delivery Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Liposomes Drug Delivery Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.2 Europe Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.3 China Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.4 Japan Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Liposomes Drug Delivery Estimates and Projections (2016-2027)
2.4.6 India Liposomes Drug Delivery Estimates and Projections (2016-2027)
3 Global Liposomes Drug Delivery Competition Landscape by Players
3.1 Global Top Liposomes Drug Delivery Players by Sales (2016-2021)
3.2 Global Top Liposomes Drug Delivery Players by Revenue (2016-2021)
3.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2020)
3.4 Global Liposomes Drug Delivery Average Price by Company (2016-2021)
3.5 Manufacturers Liposomes Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Liposomes Drug Delivery Market Size by Type
4.1 Global Liposomes Drug Delivery Historic Market Review by Type (2016-2021)
4.1.1 Global Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
4.1.2 Global Liposomes Drug Delivery Revenue Market Share by Type (2016-2021)
4.1.3 Global Liposomes Drug Delivery Price by Type (2016-2021)
4.2 Global Liposomes Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Liposomes Drug Delivery Sales Forecast by Type (2022-2027)
4.2.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2022-2027)
4.2.3 Global Liposomes Drug Delivery Price Forecast by Type (2022-2027)
5 Global Liposomes Drug Delivery Market Size by Application
5.1 Global Liposomes Drug Delivery Historic Market Review by Application (2016-2021)
5.1.1 Global Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
5.1.2 Global Liposomes Drug Delivery Revenue Market Share by Application (2016-2021)
5.1.3 Global Liposomes Drug Delivery Price by Application (2016-2021)
5.2 Global Liposomes Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Liposomes Drug Delivery Sales Forecast by Application (2022-2027)
5.2.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2022-2027)
5.2.3 Global Liposomes Drug Delivery Price Forecast by Application (2022-2027)

6 North America Liposomes Drug Delivery Market Facts & Figures
6.1 North America Liposomes Drug Delivery Sales by Company
6.1.1 North America Liposomes Drug Delivery Sales by Company (2016-2021)
6.1.2 North America Liposomes Drug Delivery Revenue by Company (2016-2021)
6.2 North America Liposomes Drug Delivery Sales Breakdown by Type
6.2.1 North America Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
6.2.2 North America Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
6.3 North America Liposomes Drug Delivery Sales Breakdown by Application
6.3.1 North America Liposomes Drug Delivery Sales Breakdown by Application (2016-2021)
6.3.2 North America Liposomes Drug Delivery Sales Breakdown by Application (2022-2027)

7 Europe Liposomes Drug Delivery Market Facts & Figures
7.1 Europe Liposomes Drug Delivery Sales by Company
7.1.1 Europe Liposomes Drug Delivery Sales by Company (2016-2021)
7.1.2 Europe Liposomes Drug Delivery Revenue by Company (2016-2021)
7.2 Europe Liposomes Drug Delivery Sales Breakdown by Type
7.2.1 Europe Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
7.2.2 Europe Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
7.3 Europe Liposomes Drug Delivery Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Liposomes Drug Delivery Market Facts & Figures
8.1 China Liposomes Drug Delivery Sales by Company
8.1.1 China Liposomes Drug Delivery Sales by Company (2016-2021)
8.1.2 China Liposomes Drug Delivery Revenue by Company (2016-2021)
8.2 China Liposomes Drug Delivery Sales Breakdown by Type
8.2.1 China Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
8.2.2 China Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
8.3 China Liposomes Drug Delivery Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)

9 Japan Liposomes Drug Delivery Market Facts & Figures
9.1 Japan Liposomes Drug Delivery Sales by Company
9.1.1 Japan Liposomes Drug Delivery Sales by Company (2016-2021)
9.1.2 Japan Liposomes Drug Delivery Revenue by Company (2016-2021)
9.2 Japan Liposomes Drug Delivery Sales Breakdown by Type
9.2.1 Japan Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
9.2.2 Japan Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
9.3 Japan Liposomes Drug Delivery Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Liposomes Drug Delivery Market Facts & Figures
10.1 Southeast Asia Liposomes Drug Delivery Sales by Company
10.1.1 Southeast Asia Liposomes Drug Delivery Sales by Company (2016-2021)
10.1.2 Southeast Asia Liposomes Drug Delivery Revenue by Company (2016-2021)
10.2 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Type
10.2.1 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Liposomes Drug Delivery Sales Breakdown by Application
10.3.1 Southeast Asia K Vial Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Vial Sales Breakdown by Application (2022-2027)

11 India Liposomes Drug Delivery Market Facts & Figures
11.1 India Liposomes Drug Delivery Sales by Company
11.1.1 India Liposomes Drug Delivery Sales by Company (2016-2021)
11.1.2 India Liposomes Drug Delivery Revenue by Company (2016-2021)
11.2 India Liposomes Drug Delivery Sales Breakdown by Type
11.2.1 India Liposomes Drug Delivery Sales Breakdown by Type (2016-2021)
11.2.2 India Liposomes Drug Delivery Sales Breakdown by Type (2022-2027)
11.3 India Liposomes Drug Delivery Sales Breakdown by Application
11.3.1 India Liposomes Drug Delivery Sales Breakdown by Application (2016-2021)
11.3.2 India Liposomes Drug Delivery Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Liposomes Drug Delivery Business
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Business Overview
12.1.3 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Liposomes Drug Delivery Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Pacira
12.2.1 Pacira Corporation Information
12.2.2 Pacira Business Overview
12.2.3 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pacira Liposomes Drug Delivery Products Offered
12.2.5 Pacira Recent Development
12.3 Sun Pharmaceutical
12.3.1 Sun Pharmaceutical Corporation Information
12.3.2 Sun Pharmaceutical Business Overview
12.3.3 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharmaceutical Liposomes Drug Delivery Products Offered
12.3.5 Sun Pharmaceutical Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Liposomes Drug Delivery Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Corporation Information
12.5.2 Luye Pharma Business Overview
12.5.3 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Luye Pharma Liposomes Drug Delivery Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Sigma-Tau Group
12.6.1 Sigma-Tau Group Corporation Information
12.6.2 Sigma-Tau Group Business Overview
12.6.3 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sigma-Tau Group Liposomes Drug Delivery Products Offered
12.6.5 Sigma-Tau Group Recent Development
12.7 Ipsen (Onivyde)
12.7.1 Ipsen (Onivyde) Corporation Information
12.7.2 Ipsen (Onivyde) Business Overview
12.7.3 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ipsen (Onivyde) Liposomes Drug Delivery Products Offered
12.7.5 Ipsen (Onivyde) Recent Development
12.8 CSPC
12.8.1 CSPC Corporation Information
12.8.2 CSPC Business Overview
12.8.3 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CSPC Liposomes Drug Delivery Products Offered
12.8.5 CSPC Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Corporation Information
12.9.2 Teva Pharmaceutical Business Overview
12.9.3 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teva Pharmaceutical Liposomes Drug Delivery Products Offered
12.9.5 Teva Pharmaceutical Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Business Overview
12.10.3 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Liposomes Drug Delivery Products Offered
12.10.5 Novartis Recent Development
12.11 Fudan-Zhangjiang
12.11.1 Fudan-Zhangjiang Corporation Information
12.11.2 Fudan-Zhangjiang Business Overview
12.11.3 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Fudan-Zhangjiang Liposomes Drug Delivery Products Offered
12.11.5 Fudan-Zhangjiang Recent Development

13 Liposomes Drug Delivery Manufacturing Cost Analysis
13.1 Liposomes Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liposomes Drug Delivery
13.4 Liposomes Drug Delivery Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liposomes Drug Delivery Distributors List
14.3 Liposomes Drug Delivery Customers

15 Market Dynamics
15.1 Liposomes Drug Delivery Market Trends
15.2 Liposomes Drug Delivery Drivers
15.3 Liposomes Drug Delivery Market Challenges
15.4 Liposomes Drug Delivery Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Liposomes Drug Delivery Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Liposomes Drug Delivery Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Liposomes Drug Delivery Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Liposomes Drug Delivery Sales (K Vial) by Region (2016-2021)
Table 5. Global Liposomes Drug Delivery Sales Market Share by Region (2016-2021)
Table 6. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Liposomes Drug Delivery Revenue Share by Region (2016-2021)
Table 8. Global Liposomes Drug Delivery Sales (K Vial) Forecast by Region (2022-2027)
Table 9. Global Liposomes Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Liposomes Drug Delivery Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Liposomes Drug Delivery Revenue Share Forecast by Region (2022-2027)
Table 12. Global Liposomes Drug Delivery Sales (K Vial) of Key Companies (2016-2021)
Table 13. Global Liposomes Drug Delivery Sales Share by Company (2016-2021)
Table 14. Global Liposomes Drug Delivery Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Liposomes Drug Delivery Revenue Share by Company (2016-2021)
Table 16. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomes Drug Delivery as of 2020)
Table 17. Global Liposomes Drug Delivery Average Price (USD/Vial) of Key Company (2016-2021)
Table 18. Manufacturers Liposomes Drug Delivery Manufacturing Sites and Area Served
Table 19. Manufacturers Liposomes Drug Delivery Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Liposomes Drug Delivery Sales (K Vial) by Type (2016-2021)
Table 22. Global Liposomes Drug Delivery Sales Share by Type (2016-2021)
Table 23. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2016-2021)
Table 25. Global Liposomes Drug Delivery Sales Share by Type (2022-2027)
Table 26. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Liposomes Drug Delivery Revenue Share by Type (2022-2027)
Table 28. Global Liposomes Drug Delivery Price (USD/Vial) by Type (2022-2027)
Table 29. Global Liposomes Drug Delivery Sales (K Vial) by Application (2016-2021)
Table 30. Global Liposomes Drug Delivery Sales Share by Application (2016-2021)
Table 31. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2016-2021)
Table 33. Global Liposomes Drug Delivery Sales (K Vial) by Application (2022-2027)
Table 34. Global Liposomes Drug Delivery Sales Share by Application (2022-2027)
Table 35. Global Liposomes Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Liposomes Drug Delivery Revenue Share by Application (2022-2027)
Table 37. Global Liposomes Drug Delivery Price (USD/Vial) by Application (2022-2027)
Table 38. North America Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 39. North America Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 40. North America Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 42. North America Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 43. North America Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 44. North America Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 45. North America Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 46. North America Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 47. North America Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 48. North America Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 49. North America Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 50. Europe Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 51. Europe Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 52. Europe Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 54. Europe Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 55. Europe Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 56. Europe Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 57. Europe Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 58. Europe Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 59. Europe Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 60. Europe Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 61. Europe Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 62. China Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 63. China Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 64. China Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 66. China Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 67. China Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 68. China Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 69. China Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 70. China Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 71. China Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 72. China Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 73. China Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 74. Japan Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 75. Japan Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 76. Japan Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 78. Japan Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 79. Japan Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 80. Japan Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 81. Japan Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 82. Japan Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 83. Japan Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 84. Japan Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 85. Japan Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 87. Southeast Asia Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 91. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 93. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 95. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 97. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 98. India Liposomes Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 99. India Liposomes Drug Delivery Sales Market Share by Company (2016-2021)
Table 100. India Liposomes Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Liposomes Drug Delivery Revenue Market Share by Company (2016-2021)
Table 102. India Liposomes Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 103. India Liposomes Drug Delivery Sales Market Share by Type (2016-2021)
Table 104. India Liposomes Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 105. India Liposomes Drug Delivery Sales Market Share by Type (2022-2027)
Table 106. India Liposomes Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 107. India Liposomes Drug Delivery Sales Market Share by Application (2016-2021)
Table 108. India Liposomes Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 109. India Liposomes Drug Delivery Sales Market Share by Application (2022-2027)
Table 110. Gilead Sciences Corporation Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 113. Gilead Sciences Liposomes Drug Delivery Product
Table 114. Gilead Sciences Recent Development
Table 115. Pacira Corporation Information
Table 116. Pacira Description and Business Overview
Table 117. Pacira Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 118. Pacira Liposomes Drug Delivery Product
Table 119. Pacira Recent Development
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 123. Sun Pharmaceutical Liposomes Drug Delivery Product
Table 124. Sun Pharmaceutical Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 128. Johnson & Johnson Liposomes Drug Delivery Product
Table 129. Johnson & Johnson Recent Development
Table 130. Luye Pharma Corporation Information
Table 131. Luye Pharma Description and Business Overview
Table 132. Luye Pharma Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 133. Luye Pharma Liposomes Drug Delivery Product
Table 134. Luye Pharma Recent Development
Table 135. Sigma-Tau Group Corporation Information
Table 136. Sigma-Tau Group Description and Business Overview
Table 137. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 138. Sigma-Tau Group Liposomes Drug Delivery Product
Table 139. Sigma-Tau Group Recent Development
Table 140. Ipsen (Onivyde) Corporation Information
Table 141. Ipsen (Onivyde) Description and Business Overview
Table 142. Ipsen (Onivyde) Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 143. Ipsen (Onivyde) Liposomes Drug Delivery Product
Table 144. Ipsen (Onivyde) Recent Development
Table 145. CSPC Corporation Information
Table 146. CSPC Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 147. CSPC Description and Business Overview
Table 148. CSPC Liposomes Drug Delivery Product
Table 149. CSPC Recent Development
Table 150. Teva Pharmaceutical Corporation Information
Table 151. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 152. Teva Pharmaceutical Description and Business Overview
Table 153. Teva Pharmaceutical Liposomes Drug Delivery Product
Table 154. Teva Pharmaceutical Recent Development
Table 155. Novartis Corporation Information
Table 156. Novartis Description and Business Overview
Table 157. Novartis Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 158. Novartis Liposomes Drug Delivery Product
Table 159. Novartis Recent Development
Table 160. Fudan-Zhangjiang Corporation Information
Table 161. Fudan-Zhangjiang Description and Business Overview
Table 162. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 163. Fudan-Zhangjiang Liposomes Drug Delivery Product
Table 164. Fudan-Zhangjiang Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Liposomes Drug Delivery Distributors List
Table 168. Liposomes Drug Delivery Customers List
Table 169. Liposomes Drug Delivery Market Trends
Table 170. Liposomes Drug Delivery Market Drivers
Table 171. Liposomes Drug Delivery Market Challenges
Table 172. Liposomes Drug Delivery Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposomes Drug Delivery Product Picture
Figure 2. Global Liposomes Drug Delivery Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liposomes Drug Delivery Sales Market Share by Application in 2021 & 2027
Figure 6. Fungal Infection Therapy Examples
Figure 7. Cancer & Tumor Therapy Examples
Figure 8. Others Examples
Figure 9. Global Liposomes Drug Delivery Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Liposomes Drug Delivery Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Liposomes Drug Delivery Sales (K Vial) Growth Rate (2016-2027)
Figure 12. Global Liposomes Drug Delivery Price Trends Growth Rate (2016-2027) (USD/Vial)
Figure 13. Global Liposomes Drug Delivery Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Liposomes Drug Delivery Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Liposomes Drug Delivery Sales (K Vial) Growth Rate (2016-2027)
Figure 17. Europe Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Liposomes Drug Delivery Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Liposomes Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Liposomes Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Liposomes Drug Delivery Players Market Share by Revenue in Liposomes Drug Delivery: 2016 & 2020
Figure 28. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Liposomes Drug Delivery Revenue Share by Type (2016-2021)
Figure 30. Global Liposomes Drug Delivery Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Liposomes Drug Delivery Revenue Share by Application (2016-2021)
Figure 32. Global Liposomes Drug Delivery Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 34. North America Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 35. Europe Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 36. Europe Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 37. China Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 38. China Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 39. Japan Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 40. Japan Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 41. Southeast Asia Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 42. Southeast Asia Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 43. India Liposomes Drug Delivery Sales Market Share by Type in 2020
Figure 44. India Liposomes Drug Delivery Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Liposomes Drug Delivery
Figure 47. Manufacturing Process Analysis of Liposomes Drug Delivery
Figure 48. Liposomes Drug Delivery Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed